APOB and metabolic dysfunction-associated steatotic liver disease: It should be noted that in model 1-3, APOB/A1 ratio had the strongest correlation with NAFLD in patients with newly diagnosed T2DM [model1 odds ratio (OR)= 10.72, P<0.001; model2 OR=4.81, P=0.001 and model3 OR= 6.25; P=0.006, respectively] (Table 2).